RIQAS TDM EQA Programme by Randox Laboratories Ltd.

RIQAS is the largest global External Quality Assessment (EQA) scheme, used by more than 35,000 participants in 123 countries.The RIQAS Therapeutic Drug EQA programme is designed to monitor the performance of an impressive 18 therapeutic drugs.Features:Weighed in values are reported for each parameterAccredited to ISO/IEC 17043. Lyophilised for enhanced stability100% human serumBi-weekly reportingSubmit results and view reports online via RIQAS.NetRegister up to five instruments at no extra costW... Read more


RIQAS TDM EQA Programme by Randox Laboratories Ltd. product image
RIQAS TDM EQA Programme

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.



0 Scientists have reviewed this product


Write the First Review

No Reviews

RIQAS is the largest global External Quality Assessment (EQA) scheme, used by more than 35,000 participants in 123 countries.

The RIQAS Therapeutic Drug EQA programme is designed to monitor the performance of an impressive 18 therapeutic drugs.

Features:

  • Weighed in values are reported for each parameter
  • Accredited to ISO/IEC 17043. Lyophilised for enhanced stability
  • 100% human serum
  • Bi-weekly reporting
  • Submit results and view reports online via RIQAS.Net
  • Register up to five instruments at no extra cost
  • Weighed in values reported for each parameter

Parameters:

  • Amikacin
  • Caffeine
  • Carbamazepine
  • Cyclosporine
  • Digoxin
  • Ethosuximide
  • Gentamicin
  • Lithium
  • Methotrexate
  • Paracetamol
  • Phenobarbital
  • Phenytoin
  • Primidone
  • Salicylic Acid
  • Theophylline
  • Tobramycin
  • Valproic Acid
  • Vancomycin

Product Overview